These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 24682267)

  • 21. Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma.
    Wang X; Björklund S; Wasik AM; Grandien A; Andersson P; Kimby E; Dahlman-Wright K; Zhao C; Christensson B; Sander B
    PLoS One; 2010 Nov; 5(11):e14085. PubMed ID: 21124928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1.
    Zukerberg LR; Benedict WF; Arnold A; Dyson N; Harlow E; Harris NL
    Blood; 1996 Jul; 88(1):268-76. PubMed ID: 8704183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib.
    Jain P; Kanagal-Shamanna R; Zhang S; Ahmed M; Ghorab A; Zhang L; Ok CY; Li S; Hagemeister F; Zeng D; Gong T; Chen W; Badillo M; Nomie K; Fayad L; Medeiros LJ; Neelapu S; Fowler N; Romaguera J; Champlin R; Wang L; Wang ML
    Br J Haematol; 2018 Nov; 183(4):578-587. PubMed ID: 30175400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoglobulin V(H) gene mutational analysis suggests that blastic variant of mantle cell lymphoma derives from different stages of B-cell maturation.
    László T; Nagy M; Kelényi G; Matolcsy A
    Leuk Res; 2000 Jan; 24(1):27-31. PubMed ID: 10634642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma.
    M'kacher R; Bennaceur A; Farace F; Laugé A; Plassa LF; Wittmer E; Dossou J; Violot D; Deutsch E; Bourhis J; Stoppa-Lyonnet D; Ribrag V; Carde P; Parmentier C; Bernheim A; Turhan AG
    Oncogene; 2003 Sep; 22(39):7905-12. PubMed ID: 12970738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonimmunoglobulin gene hypermutation in germinal center B cells.
    Peng HZ; Du MQ; Koulis A; Aiello A; Dogan A; Pan LX; Isaacson PG
    Blood; 1999 Apr; 93(7):2167-72. PubMed ID: 10090923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma.
    Wagener R; Seufert J; Raimondi F; Bens S; Kleinheinz K; Nagel I; Altmüller J; Thiele H; Hübschmann D; Kohler CW; Nürnberg P; Au-Yeung R; Burkhardt B; Horn H; Leoncini L; Jaffe ES; Ott G; Rymkiewicz G; Schlesner M; Russell RB; Klapper W; Siebert R
    Blood; 2019 Feb; 133(9):962-966. PubMed ID: 30567752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomas.
    Lunning MA; Green MR
    Blood Cancer J; 2015 Oct; 5(10):e361. PubMed ID: 26473533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flipping the cyclin D1 switch in mantle cell lymphoma.
    Hasanali Z; Sharma K; Epner E
    Best Pract Res Clin Haematol; 2012 Jun; 25(2):143-52. PubMed ID: 22687450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mantle cell lymphoma with aberrant expression of CD10.
    Zanetto U; Dong H; Huang Y; Zhang K; Narbaitz M; Sapia S; Kostopoulos I; Liu H; Du MQ; Bacon CM
    Histopathology; 2008 Jul; 53(1):20-9. PubMed ID: 18518902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia.
    Chakrabarty S; Varghese VK; Sahu P; Jayaram P; Shivakumar BM; Pai CG; Satyamoorthy K
    Br J Cancer; 2017 Jun; 117(1):136-143. PubMed ID: 28524162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma.
    Özoğul E; Montaner A; Pol M; Frigola G; Balagué O; Syrykh C; Bousquets-Muñoz P; Royo R; Fontaine J; Traverse-Glehen A; Bühler MM; Giudici L; Roncador M; Zenz T; Carras S; Valmary-Degano S; de Leval L; Bosch-Schips J; Climent F; Salmeron-Villalobos J; Bashiri M; Ruiz-Gaspà S; Costa D; Beà S; Salaverria I; Giné E; Quintanilla-Martinez L; Brousset P; Raffeld M; Jaffe ES; Puente XS; López C; Nadeu F; Campo E
    Blood Cancer J; 2024 Sep; 14(1):166. PubMed ID: 39313500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies.
    Cani AK; Soliman M; Hovelson DH; Liu CJ; McDaniel AS; Haller MJ; Bratley JV; Rahrig SE; Li Q; Briceño CA; Tomlins SA; Rao RC
    Mod Pathol; 2016 Jul; 29(7):685-97. PubMed ID: 27102345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma.
    Kanduri M; Sander B; Ntoufa S; Papakonstantinou N; Sutton LA; Stamatopoulos K; Kanduri C; Rosenquist R
    Epigenetics; 2013 Dec; 8(12):1280-8. PubMed ID: 24107828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TP53 mutations are common in mantle cell lymphoma, including the indolent leukemic non-nodal variant.
    Sakhdari A; Ok CY; Patel KP; Kanagal-Shamanna R; Yin CC; Zuo Z; Hu S; Routbort MJ; Luthra R; Medeiros LJ; Khoury JD; Loghavi S
    Ann Diagn Pathol; 2019 Aug; 41():38-42. PubMed ID: 31132650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances.
    Camacho E; Hernández L; Hernández S; Tort F; Bellosillo B; Beà S; Bosch F; Montserrat E; Cardesa A; Fernández PL; Campo E
    Blood; 2002 Jan; 99(1):238-44. PubMed ID: 11756177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage.
    Queirós AC; Beekman R; Vilarrasa-Blasi R; Duran-Ferrer M; Clot G; Merkel A; Raineri E; Russiñol N; Castellano G; Beà S; Navarro A; Kulis M; Verdaguer-Dot N; Jares P; Enjuanes A; Calasanz MJ; Bergmann A; Vater I; Salaverría I; van de Werken HJG; Wilson WH; Datta A; Flicek P; Royo R; Martens J; Giné E; Lopez-Guillermo A; Stunnenberg HG; Klapper W; Pott C; Heath S; Gut IG; Siebert R; Campo E; Martín-Subero JI
    Cancer Cell; 2016 Nov; 30(5):806-821. PubMed ID: 27846393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiparameter immunohistochemical analysis of the cell cycle proteins cyclin D1, Ki-67, p21WAF1, p27KIP1, and p53 in mantle cell lymphoma.
    Izban KF; Alkan S; Singleton TP; Hsi ED
    Arch Pathol Lab Med; 2000 Oct; 124(10):1457-62. PubMed ID: 11035575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1.
    Teo AE; Chen Z; Miranda RN; McDonnell T; Medeiros LJ; McCarty N
    Leukemia; 2016 Mar; 30(3):580-93. PubMed ID: 26073757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma.
    Grønbaek K; Worm J; Ralfkiaer E; Ahrenkiel V; Hokland P; Guldberg P
    Blood; 2002 Aug; 100(4):1430-7. PubMed ID: 12149228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.